$427 Million is the total value of JW Asset Management, LLC's 10 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 60.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESTA | ESTABLISHMENT LABS HLDGS INC | $272,281,000 | +39.7% | 3,117,485 | 0.0% | 63.69% | +13.6% | |
| AMZN | AMAZON COM INC | $83,070,000 | +11.2% | 24,147 | 0.0% | 19.43% | -9.6% | |
| GRWG | GROWGENERATION CORP | $61,015,000 | -3.2% | 1,268,500 | 0.0% | 14.27% | -21.3% | |
| HZNP | HORIZON THERAPEUTICS PUB L | $4,745,000 | +1.7% | 50,673 | 0.0% | 1.11% | -17.3% | |
| PHAR | Sell | PHARMING GROUP NVspon ads | $1,907,000 | -21.6% | 169,225 | -10.7% | 0.45% | -36.3% |
| HYFM | HYDROFARM HLDGS GROUP INC | $1,478,000 | -2.0% | 25,000 | 0.0% | 0.35% | -20.3% | |
| MSOS | New | ADVISORSHARES TRpure us cannabis | $1,137,000 | – | 28,410 | +100.0% | 0.27% | – |
| MSAC | New | MEDICUS SCIENCES ACQUISITION | $965,000 | – | 100,000 | +100.0% | 0.23% | – |
| HMCOU | HUMANCO ACQUISITION CORPunit 12/08/2023 | $880,000 | -1.9% | 85,000 | 0.0% | 0.21% | -20.2% | |
| MSACW | New | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $11,000 | – | 11,100 | +100.0% | 0.00% | – |
| Exit | ALIMERA SCIENCES INC | $0 | – | -27,552 | -100.0% | -0.08% | – | |
| MSACU | Exit | MEDICUS SCIENCES ACQUISITIONunit 99/99/9999 | $0 | – | -100,000 | -100.0% | -0.28% | – |
| AFCG | Exit | AFC GAMMA INC | $0 | – | -200,000 | -100.0% | -1.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-06
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
| ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
| EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
| HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
| HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
| LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
| BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
| MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
| CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
| EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 4 | 2024-01-02 |
| SC 13D/A | 2024-01-02 |
| 4 | 2023-12-26 |
| 4 | 2023-12-19 |
| 4 | 2023-12-12 |
| 4 | 2023-12-07 |
| 4 | 2023-12-06 |
| 4 | 2023-11-21 |
| 4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.